Vivaldi Capital Management »

Lenz Therapeutics shares owned by Vivaldi Capital Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Vivaldi Capital Management from 13F filings

Historical chart of Vivaldi Capital Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Vivaldi Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Vivaldi Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.4M 59k 23.74
2024-06-30 $1.0M 59k 17.29
2024-03-31 $924k 59k 15.73

More positions owned by Vivaldi Capital Management

Spdr Ser Tr Portfolio S&p500 (SPLG)
Apple (AAPL)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Gold Tr Ishares New (IAU)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Tesla Motors (TSLA)
Gaming & Leisure Pptys (GLPI)
Spdr Ser Tr Portfolio S&p400 (SPMD)

View all positions for Vivaldi Capital Management

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
EcoR1 Capital
Samsara BioCapital
72 Investment Holdings
BlackRock
Vanguard Group
BlackRock
Point72 Asset Management
Tang Capital Management
T. Rowe Price Associates
Geode Capital Management
State Street Corporation
Ikarian Capital
Northern Trust

View all funds holding Lenz Therapeutics